InvestorsHub Logo
Followers 269
Posts 8489
Boards Moderated 0
Alias Born 10/05/2010

Re: None

Sunday, 01/22/2017 12:07:26 PM

Sunday, January 22, 2017 12:07:26 PM

Post# of 209
For those who like the read the science behind something, this is a good article on NewGen's proprietary Micellar Nanoparticle (MNP) technology. MNP is a transdermal drug delivery platform, one of 3 that have an FDA approved product. There have only been 13 FDA approved nano-drugs thus far and NewGen has the rights to one, Estrasorb, everywhere except North America.

Elan Corporation was the leading nanoformulation company and successfully re-formulated the majority of the 13 approved nano-products. Elan sold its delivery business to Alkermis for $980 Million in 2011.

NewGen acquired the MNP technology from Novavax, Inc.(Nasdaq:NVAX) back in 2010. Novavax had spent 10 years and $100M dollars developing the first generation of the platform, and NewGen spent the next 10 years improving it.


http://www.particlesciences.com/docs/Micellar_Nanoparticles-Applications_for_Topical.pdf

WELCOME TO